Patrick Temple-West
U.S. pharmaceutical correspondent for the Financial Times, covering pharma industry developments, regulatory and commercial issues including obesity and diabetes drugs.
Best podcasts with Patrick Temple-West
Ranked by the Snipd community
101 snips
Feb 10, 2026 • 12min
Novo Nordisk hits back at copycat drugs
Josh Franklin, U.S. banking editor focused on regulation and bank stability, and Patrick Temple-West, U.S. pharma correspondent tracking obesity and diabetes drugs, discuss Novo Nordisk’s lawsuit over alleged copycat weight-loss pills. They also cover gilts’ market moves, France’s central bank chief stepping down, and U.S. debate on boosting deposit insurance to prevent another SVB-style run.
24 snips
Feb 20, 2026 • 22min
Maha’s big reversal and a Scotus decision on tariffs
Brooke Masters, FT U.S. managing editor focusing on healthcare and policy, and Patrick Temple-West, FT pharmaceuticals correspondent tracking FDA and biotech, unpack a rapid FDA reversal on Moderna’s flu trial. They also break down the Supreme Court ruling on Trump’s tariffs and what it means for trade policy. Short, sharp takes on political maneuvering around drug pricing and public health.
